These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

622 related articles for article (PubMed ID: 12474051)

  • 1. DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study.
    Bazan V; Migliavacca M; Zanna I; Tubiolo C; Corsale S; Calò V; Amato A; Cammareri P; Latteri F; Grassi N; Fulfaro F; Porcasi R; Morello V; Nuara RB; Dardanoni G; Salerno S; Valerio MR; Dusonchet L; Gerbino A; Gebbia N; Tomasino RM; Russo A
    J Cancer Res Clin Oncol; 2002 Dec; 128(12):650-8. PubMed ID: 12474051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nm23-H1 expression does not predict clinical survival in colorectal cancer patients.
    Dusonchet L; Corsale S; Migliavacca M; Calò V; Bazan V; Amato A; Cammareri P; Totaro MS; Agnese V; Cascio S; La Rocca G; Sisto PS; Dardanoni G; Valerio MR; Grassi N; Latteri S; Cajozzo M; Buscemi M; Castorina S; Morello V; Tomasino RM; Gebbia N; Russo A
    Oncol Rep; 2003; 10(5):1257-63. PubMed ID: 12883690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nm23-H1 protein, DNA-ploidy and S-phase fraction in relation to overall survival and disease free survival in transitional cell carcinoma of the bladder.
    Alderisio M; Cenci M; Valli C; Russo A; Bazan V; Dardanoni G; Cucciarre S; Carreca I; Macaluso MP; Tomasino RM; Vecchione A
    Anticancer Res; 1998; 18(6A):4225-30. PubMed ID: 9891471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 mutations in L3-loop zinc-binding domain, DNA-ploidy, and S phase fraction are independent prognostic indicators in colorectal cancer: a prospective study with a five-year follow-up.
    Russo A; Migliavacca M; Zanna I; Valerio MR; Latteri MA; Grassi N; Pantuso G; Salerno S; Dardanoni G; Albanese I; La Farina M; Tomasino RM; Gebbia N; Bazan V
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1322-31. PubMed ID: 12433709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of DNA ploidy, S-phase fraction, and tissue levels of aspartic, cysteine, and serine proteases in operable gastric carcinoma.
    Russo A; Bazan V; Migliavacca M; Zanna I; Tubiolo C; Tumminello FM; Dardanoni G; Cajozzo M; Bazan P; Modica G; Latteri M; Tomasino RM; Colucci G; Gebbia N; Leto G
    Clin Cancer Res; 2000 Jan; 6(1):178-84. PubMed ID: 10656448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma.
    Tomić S; Ilić Forko J; Babić D; Sundov D; Kuret S; Andelinović S
    Croat Med J; 2003 Aug; 44(4):429-34. PubMed ID: 12950146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TP53 mutations and S-phase fraction but not DNA-ploidy are independent prognostic indicators in laryngeal squamous cell carcinoma.
    Russo A; Corsale S; Agnese V; Macaluso M; Cascio S; Bruno L; Surmacz E; Dardanoni G; Valerio MR; Vieni S; Restivo S; Fulfaro F; Tomasino RM; Gebbia N; Bazan V
    J Cell Physiol; 2006 Jan; 206(1):181-8. PubMed ID: 15965904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical analysis of nm23-H1 in stage I non-small cell lung cancer: a useful marker in prediction of metastases.
    Lai WW; Wu MH; Yan JJ; Chen FF
    Ann Thorac Surg; 1996 Nov; 62(5):1500-4. PubMed ID: 8893591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prediction of lymph node metastases in colorectal cancer by expression of the nucleoside diphosphate kinase/nm23-H1 and histopathological variables.
    Tannapfel A; Katalinic A; Köckerling F; Wittekind C
    Am J Gastroenterol; 1997 Jul; 92(7):1182-6. PubMed ID: 9219795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of NDP kinase nm23 associated with ploidy image analysis in colorectal cancer.
    Giarnieri E; Alderisio M; Valli C; Vecchione A; Forte A; Turano R; Pulcini M
    Anticancer Res; 1995; 15(5B):2049-53. PubMed ID: 8572601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlates of urokinase-type plasminogen activator in colorectal cancer: positive relationship with nm23 and c-erbB-2 protein expression.
    Berney CR; Yang J; Fisher RJ; Russell PJ; Crowe PJ
    Oncol Res; 1998; 10(1):47-54. PubMed ID: 9613457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of both NM23-h1 and NM23-H2 expression identifies "at-risk" patients with colorectal cancer.
    Brenner AS; Thebo JS; Senagore AJ; Duepree HJ; Gramlich T; Ormsby A; Lavery IC; Fazio VW
    Am Surg; 2003 Mar; 69(3):203-8; discussion 208. PubMed ID: 12678475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. nm23 protein expression in colorectal carcinoma metastasis in regional lymph nodes and the liver.
    Sarris M; Lee CS
    Eur J Surg Oncol; 2001 Mar; 27(2):170-4. PubMed ID: 11289754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of nm23-H1 in transitional cell carcinoma of the upper urinary tract.
    Cheng HL; Tong YC; Tzai TS; Weng CL; Ho CL; Yang WH; Lin JS; Chow NH
    Oncol Rep; 2001; 8(1):193-6. PubMed ID: 11115597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Separating favorable from unfavorable prognostic markers in breast cancer: the role of E-cadherin.
    Heimann R; Lan F; McBride R; Hellman S
    Cancer Res; 2000 Jan; 60(2):298-304. PubMed ID: 10667580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic markers of the epithelial tumors of the large intestine].
    Forte A; D'Urso A; Gallinaro LS; Lo Storto G; Covotta A; Soda G; Bosco D; Nardoni S; Bezzi M; Beltrami V
    Ann Ital Chir; 2002; 73(6):587-96; discussion 597. PubMed ID: 12820582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: a North Central Cancer Treatment Group Study.
    Garrity MM; Burgart LJ; Mahoney MR; Windschitl HE; Salim M; Wiesenfeld M; Krook JE; Michalak JC; Goldberg RM; O'Connell MJ; Furth AF; Sargent DJ; Murphy LM; Hill E; Riehle DL; Meyers CH; Witzig TE;
    J Clin Oncol; 2004 May; 22(9):1572-82. PubMed ID: 15117979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of Ki-67 expression, ploidy and S-phase fraction in patients with pancreatic cancer.
    Lundin J; Nordling S; von Boguslawsky K; Roberts PJ; Haglund C
    Anticancer Res; 1995; 15(6B):2659-68. PubMed ID: 8669843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the prognostic value of a panel of tissue tumor markers and established clinicopathological factors in patients with gastric cancer.
    Wiksten JP; Lundin J; Nordling S; Kokkola A; Haglund C
    Anticancer Res; 2008; 28(4C):2279-87. PubMed ID: 18751407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allelic imbalance at NME1 in microdissected primary and metastatic human colorectal carcinomas is frequent but not associated with metastasis to lymph nodes or liver.
    Lamb RF; Going JJ; Pickford I; Birnie GD
    Cancer Res; 1996 Feb; 56(4):916-20. PubMed ID: 8631033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.